Plus Pharma
NDC Package 51645-735-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Plus Pharma is a . Marketed by Gemini Pharmaceuticals, Inc. Dba Plus Pharma, this product is identified by NDC 51645-735 and is authorized under FDA application part331.

Identification & Billing

NDC Package Code
51645-735-15
Package Description
150 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Product Code
51645-735
11-Digit Billing Format
51645073515

Clinical Specifications

Proprietary Name
Plus Pharma Calcium Antacid
Dosage Form
-

Regulatory & Marketing

Labeler Name
Gemini Pharmaceuticals, Inc. Dba Plus Pharma
FDA Application #
part331
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-27-2006
End Marketing Date
03-31-2022
Listing Expiration
03-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51645-735-15 identifies a specific commercial package of 150 tablet, chewable in 1 bottle, plastic of Plus Pharma Calcium Antacid, labeled by Gemini Pharmaceuticals, Inc. Dba Plus Pharma. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Gemini Pharmaceuticals, Inc. Dba Plus Pharma on March 27, 2006. The current certification is valid through March 31, 2022.

How is this Gemini Pharmaceuticals, Inc. Dba Plus Pharma product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51645073515. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51645-735-15
11-Digit CMS (5-4-2)
51645-0735-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.